Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 4R42CA275665 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
| Wake Forest University Health Sciences | OTHER |
Not provided
Not provided
Not provided
Not provided
mPATH-CRC (mobile Patient Technology for Health) is an automated direct-to-patient digital health program about colorectal cancer screening. The goal of this project is to test a cloud-based version of mPATH that patients can use at home independent of a scheduled medical visit. Patients will access mPATH on their own devices using a hyperlink sent via text message. The cloud version of mPATH will have the proven effective content of the tablet version, including the ability to request a screening test directly via the program. mPATH will then share this information with the patient's healthcare organization so screening can be arranged. This cloud-based version will be highly scalable, have broad reach, and be easy to support, making it a commercially viable product. This project will (1) test the reach and effectiveness of the mPATH web app in two different healthcare settings: a Fee-for-Service setting, and a value-based care setting; and (2) determine the value generated by mPATH in each healthcare setting.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| mPATH-CRC | Experimental | Participants randomized to the mPATH arm will receive a text message inviting them to use the mPATH-CRC WebApp. The WebApp verifies individuals are due for routine colorectal cancer (CRC) screening, educates them about their options, and lets them request a screening test via the program. |
|
| Usual Care (Control) | Placebo Comparator | Patients randomized to the control arm will receive usual care, which includes the organizations' standard procedures for addressing CRC screening. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| mPATH-CRC | Other | Individuals will receive an automated text message inviting them to use the mPATH-CRC WebApp. The WebApp takes approximately 5 to 8 minutes to complete. The WebApp verifies patients are due for routine CRC screening, educates them about their options, and lets them request a screening test via the program. |
| Measure | Description | Time Frame |
|---|---|---|
| Effectiveness of mPATH-CRC | The proportion of individuals who complete a CRC screening test (colonoscopy, FIT, or FIT-DNA) within 180 days of randomization in both arms | 180 Days |
| Measure | Description | Time Frame |
|---|---|---|
| Reach of mPATH-CRC | The proportion of patients in the mPATH-CRC arm who complete the mPATH-CRC Web App to the point of being told if screening is due or not due | 30 Days |
| Reporting current CRC screening |
Not provided
Inclusion Criteria:
Age 45-74 years
Be identified in the electronic health record as due for routine CRC screening, defined as
Have a cell phone number listed in the EHR
Have a preferred language of English or Spanish in the EHR
Upcoming appointment within 9 to 16 days
Georgia Market Only: Insurance type is listed as Medicare Advantage.
Exclusion Criteria
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Atrium Health Floyd | Rome | Georgia | 30161 | United States | ||
| Atrium Health Wake Forest Baptist |
We will share de-identified individual participant data that underlie our published or presented results.
Within one year of the publication of the study's results. Data will be kept available until 4 years after the publication of the study's results.
Researchers must provide the investigative team a methodologically sound proposal. Use of the data will be limited to achieve the aims in their submitted proposal. To gain access, data requestors will need to sign a data access agreement.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Usual Care (Control) | Other | Patients randomized to the control arm will receive usual care, which includes the organizations' standard procedures for addressing CRC screening. In the participating Fee-for-Service and Value-Based settings, the EHR flags patients who are overdue for CRC screening as a "care gap" that is visible to all primary care providers. |
|
The proportion of participants within the mPATH arm who report they are current with CRC screening within the mPATH program.
| 30 Days |
| CRC screening ordered | The proportion of patients who have a CRC screening test ordered within 180 days of randomization in both arms. | 180 Days |
| Colorectal Neoplasia | The proportion of patients in each arm with neoplasia found on colonoscopy within 180 days after randomization. | 180 days |
| Mean revenue generated in a Fee-for-Service setting | Mean revenue generated in a Fee-for-Service setting from screening and resulting downstream care within 12 months (365 days) of the screening event, assuming Medicare reimbursement rates in both arms. | 365 Days |
| Quality gaps closed in a value-based care setting | Proportion of quality gaps closed in a value-based setting in each arm defined as completing screening or acquiring documentation of previously completed screening in both arms. | 180 Days |
| Winston-Salem |
| North Carolina |
| 27157 |
| United States |